About UO Oncologia Medica IRCCS IRST
"Frutto dell’alleanza tra soggetti pubblici e appartenenti al privato sociale, l’Istituto Scientifico Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST è riferimento nazionale in campo oncologico. La sua missione consiste nel promuovere e realizzare attività di cura, studio e ricerca, in particolare ricerca traslazionale. Operativo dal 2007 all’interno delle strutture dell'ex Ospedale Civile di Meldola (Forlì-Cesena) ha sedi a Forlì, Cesena e Ravenna (Radioterapia) ed è riconosciuto quale Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
11
Gruppo Italiano Malattie EMatologiche dell'Adulto
5
Clinical Trials at UO Oncologia Medica IRCCS IRST
During the past decade, UO Oncologia Medica IRCCS IRST conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Pre-Operative Or Peri-Operative Dox Regimen In Patients With Locally Advanced Resectable Gastric Cancer
2010-09-01
2017-03-01
Completed
90
Radiotherapy as an Immunological Booster in Patients With Metastatic Melanoma or Renal Cell Carcinoma Treated With High-dose Interleukin-2
2012-07-09
2022-06-01
Unknown status
35
Myocet + Cyclophosphamide + Metformin Vs Myocet + Cyclophosphamide in 1st Line Treatment of HER2 Neg. Metastatic Breast Cancer Patients
2010-09-01
2015-05-01
Completed
126
Gemcitabine in Combination With Pemetrexed Long Term Infusion in the Treatment of Pretreated Metastatic Colorectal Cancer Patients
2012-07-01
2014-03-01
Completed
18
Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE)
2013-10-11
2021-07-01
Unknown status
52
A Study of Lapatinib in Combination With Caelyx in Patients With Advanced HER2 Positive Pretreated Breast Cancer
2009-12-01
2016-01-01
Terminated
11
PRednisone Plus EVerolimus in Patients With Metastatic Renal Cell Cancer After Failure of VEGFR -TKI
2015-09-22
2017-09-01
Terminated
8
Olaparib as Salvage Treatment for Cisplatin-resistant Germ Cell Tumor
2015-09-11
2021-06-01
Unknown status
18
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "UO Oncologia Medica IRCCS IRST"
#1 collaborator was "Agenzia Italiana del Farmaco" with 1 trials as a collaborator and "ERIC Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at UO Oncologia Medica IRCCS IRST
According to Clinical.Site data, the most researched conditions in "UO Oncologia Medica IRCCS IRST" are
"AML, Adult" (1 trials), "Acute Lymphoid Leukemia" (1 trials), "Adjuvant Drug Therapy" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Chronic Myeloid Leukemia" (1 trials). Many other conditions were trialed in "UO Oncologia Medica IRCCS IRST" in a lesser frequency.
Clinical Trials Intervention Types at UO Oncologia Medica IRCCS IRST
Most popular intervention types in "UO Oncologia Medica IRCCS IRST" are "Drug" (12 trials), "Other" (2 trials), "Biological" (1 trials), "Genetic" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Arm A : Gemcitabine + Pemetrexed" (1 trials), "Autologous Dendritic Cell vaccine" (1 trials), "Boost of radiotherapy + high dose IL-2 treatment" (1 trials), "DOX 2 cycles - Surgery - DOX 2 cycles" (1 trials) and "DOX 4 cycles - Surgery" (1 trials). Other intervention names were less common.
Clinical Trials Genders at UO Oncologia Medica IRCCS IRST
The vast majority of trials in "UO Oncologia Medica IRCCS IRST" are
13 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at UO Oncologia Medica IRCCS IRST
Currently, there are NaN active trials in "UO Oncologia Medica IRCCS IRST".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in UO Oncologia Medica IRCCS IRST,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in UO Oncologia Medica IRCCS IRST, 1 "Phase 1"
clinical trials were conducted, 12 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".